Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 27:

DaVita Inc. DVA: This kidney dialysis company has a Zacks Rank #1, and has

CoreWeave Reaches $5 Billion in Revenue

Thursday, CoreWeave (CRWV) reported Q4 earnings results after the market close. The large-scale GPU-accelerated operator reached an impressive milestone,

Amphastar Pharmaceuticals (AMPH) reported $183.11 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 1.8%. EPS of $0.73 for the same period compares to

Liberty Media Corporation - Liberty Formula One Series A (FWONA) came out with quarterly earnings of $0.39 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss

Liberty Media Corporation - Liberty Formula One Series C (FWONK) came out with quarterly earnings of $0.39 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss

Goldman Sachs BDC (GSBD) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.47 per share a year ago. These

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.07 per share a year ago. These figures

PureCycle Technologies, Inc. (PCT) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.29 per share a year ago

The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. The period has so far been positive, with growth remaining strong and a solid number of companies